PlainPill

Vinpocetine

The short answer. People are split on Vinpocetine — 50% of 57 say it helped. It is most often used for focus: 83% of 36 reports say that improved. It is well studied — 13 meta-analyses on PubMed. The most common complaint is headache.

What users report
50%helped57 reports · medium confidence
29 helped10 mixed18 didn't help

From 205 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
13
meta-analyses
20
RCTs
712
papers

What Vinpocetine does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 13 meta-analyses on PubMed ↗ · 20 randomized trials ↗

Cochrane Database Syst Rev · 2003 · Meta-analysis / systematic review
Vinpocetine for cognitive impairment and dementia

Conclusion: Although the basic science is interesting, the evidence for beneficial effect of vinpocetine on patients with dementia is inconclusive and does not support clinical use. The drug seems to have few adverse effects at the doses used in the studies. Large studies evaluating the use of vinpocetine for people suffering from well defined types of cognitive impairment are needed to explore possible efficacy of this treatment.

PubMed 12535455 ↗
Registered clinical trials

9 human trials on ClinicalTrials.gov test Vinpocetine — 5 completed, 1 recruiting now. See all on ClinicalTrials.gov ↗

Reports to the FDA

Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.

15 reports name a product containing Vinpocetine (2008–2019); 9 involved hospitalization or worse. Most often reported:

  • Burning sensation · 3
  • Thrombosis · 2
  • Dyspnoea · 2
  • Hallucination · 2
  • Pruritus · 2
  • Fatigue · 2

A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US government research funding (NIH)

NIH has funded 1 research project with Vinpocetine in the title, $564,126 in total (2024–2025). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

30 mgdivided doses
10 mg3x daily
10 mg2-3x daily
10 mgsplit into 3 doses
20mgdaily
15mgas reported

Reported side effects

How often each side effect came up across all reports.

headache ×3tingling ×1irritability ×1overstimulation ×1melancholy ×1depression ×1difficulty breathing ×1low energy ×1

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I also noticed a big boost after introducing Vinpocetine and Huperzine A.”
HelpedRead the discussion ↗
“I noticed that I was feeling a bit melancholy after using it for a few weeks.”
MixedRead the discussion ↗
“I tried Vinpocetine and gingko biloba for the same effect, but with cero results.”
Didn't helpRead the discussion ↗
“I didn't really see much difference in my cognitive functions using vinpo.”
Didn't helpRead the discussion ↗
Read more Vinpocetine reviews →
Top discussions (5)

Other options for focus

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate